These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Major depressive disorder induced by prolactinoma--a case report. Liao WT; Bai YM Gen Hosp Psychiatry; 2014; 36(1):125.e1-2. PubMed ID: 24182617 [TBL] [Abstract][Full Text] [Related]
3. [Hyperprolactinemia]. Müller OA; von Werder K Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201 [No Abstract] [Full Text] [Related]
7. Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease. Gheri RG; Boddi W; Ammannati F; Olivotto J; Nozzoli C; Franchi A; Bordi L; Luisi ML; Mennonna P J Endocrinol Invest; 1997 Apr; 20(4):240-4. PubMed ID: 9211134 [TBL] [Abstract][Full Text] [Related]
8. Index of suspicion. Pediatr Rev; 2004 Feb; 25(2):68-73. PubMed ID: 14754929 [No Abstract] [Full Text] [Related]
9. Hyperprolactinaemia associated with a complex cystic pituitary mass: medical versus surgical therapy. Inder WJ; Macfarlane MR Intern Med J; 2004; 34(9-10):573-6. PubMed ID: 15482272 [TBL] [Abstract][Full Text] [Related]
10. Unusual late development of dopamine agonist resistance in two women with hyperprolactinaemia associated with transition from micro to macroadenoma. McCall D; Hunter SJ; Cooke RS; Herron B; Sheridan B; Atkinson AB Clin Endocrinol (Oxf); 2007 Jan; 66(1):149-50. PubMed ID: 17201816 [No Abstract] [Full Text] [Related]
13. [Prolactinoma as a cause of primary amenorrhea in a 16-year-old girl]. Beń-Skowronek I; Szewczyk L; Witkowski D Ginekol Pol; 1999 May; 70(5):367-9. PubMed ID: 10462983 [TBL] [Abstract][Full Text] [Related]
15. Unexpected prevalence of hyperprolactinaemia associated with microprolactinoma and empty sella in a cohort of adult patients with non-transfusion-dependent thalassaemia: a prospective study. Ricchi P; Ammirabile M; Spasiano A; Costantini S; Vitale M; Di Matola T; Cinque P; Filosa A; Serino D Br J Haematol; 2014 Mar; 164(5):743-5. PubMed ID: 24251449 [No Abstract] [Full Text] [Related]
18. Hyperprolactinaemia. Prabhakar VK; Davis JR Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):341-53. PubMed ID: 17889620 [TBL] [Abstract][Full Text] [Related]
19. Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma. Barber TM; Kenkre J; Garnett C; Scott RV; Byrne JV; Wass JA Clin Endocrinol (Oxf); 2011 Dec; 75(6):819-24. PubMed ID: 21645021 [TBL] [Abstract][Full Text] [Related]